Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Psychopharmacology

• Publication date

  2005-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-004-2028-yPMID 15765256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generalised Anxiety Disorder

  2012cited by this paper
• Benzodiazepines, memory and mood: a review

  2006cited by this paper
• Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil

  2005cited by this paper
• Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment

  2005cited by this paper
• Footshock-induced freezing behavior in rats as a model for assessing anxiolytics

  2005cited by this paper
• Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood

  2005cited by this paper
• Benzodiazepines and vigilance performance: a review

  2004cited by this paper
• Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats

  2004influential reference
• The corticotropin-releasing factor receptor 1 antagonist CP-154,526 reverses stress-induced learning deficits in mice.

  2003cited by this paper
• Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors.

  2002influential reference
• 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related

  2002cited by this paper
• Reduction of Stress-Induced Behavior by Antagonism of Corticotropin-Releasing Hormone 2 (CRH2) Receptors in Lateral Septum or CRH1 Receptors in Amygdala

  2002cited by this paper
• Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders.

  2002cited by this paper
• Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders.

  2002cited by this paper
• Cognitive and sedative effects of benzodiazepine use.

  2002cited by this paper
• The CRF1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats

  2002influential reference
• Priming of Long-Term Potentiation in Mouse Hippocampus by Corticotropin-Releasing Factor and Acute Stress: Implications for Hippocampus-Dependent Learning

  2002influential reference
• Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention.

  2001influential reference
• Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice.

  2001influential reference
• Role of CRF(1) and CRF(2) receptors in fear and anxiety.

  2001cited by this paper
• Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.

  2001cited by this paper
• Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultrasonic vocalization in rats.

  2000influential reference
• The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist.

  2000influential reference
• 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist.

  2000influential reference
• Suppression of Conditioned Fear by Administration of CRF Receptor Antagonist CP-154,526

  2000cited by this paper
• Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.

  1999cited by this paper
• Neuropeptide abnormalities in patients with early Alzheimer disease.

  1999cited by this paper
• Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2

  1999influential reference
• The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.

  1999cited by this paper
• Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

  1999influential reference
• Proactive interference and temporal context encoding after diazepam intake

  1998cited by this paper
• Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine

  1998cited by this paper
• Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

  1998cited by this paper
• Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents Comparison with diazepam and buspirone

  1998cited by this paper
• Dissociable Long-Term Cognitive Deficits after Frontal versus Sensorimotor Cortical Contusions

  1998influential reference
• Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

  1997cited by this paper
• Expression of a delta 9 14:0-acyl carrier protein fatty acid desaturase gene is necessary for the production of omega 5 anacardic acids found in pest-resistant geranium (Pelargonium xhortorum).

  1996cited by this paper
• Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor.

  1996influential reference
• Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

  1995influential reference
• Diazepam impairs place learning in naive but not in maze-experienced rats in the Morris water maze

  1994cited by this paper
• Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of agoraphobia with panic disorder

  1994cited by this paper
• Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze.

  1993cited by this paper
• Diazepam impairs place learning in the Morris water maze.

  1991cited by this paper
• Diazepam impairs acquisition but not performance in the Morris water maze.

  1991cited by this paper
• Differential influences of corticotropin-releasing factor on memory retention of aversive learning and appetitive learning in rats.

  1989cited by this paper
• CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites.

  1989influential reference
• Conditional analgesia, defensive freezing, and benzodiazepines.

  1988cited by this paper
• Cognitive impairment in long-term benzodiazepine users

  1988cited by this paper
• Chlordiazepoxide, an anxiolytic benzodiazepine, impairs place navigation in rats.

  1987cited by this paper
• Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy

  1987influential reference
• Spinal fluid CRF reduction in Alzheimer's disease.

  1986influential reference
• Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

  1986influential reference
• Differential behavioral actions of corticotropin-releasing factor (CRF).

  1984cited by this paper
• Corticotrophin releasing factor is more potent than some corticotrophin-related peptides in affecting passive avoidance behaviour in rats.

  1983cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress*

  year unknowncited by this paper

• Learned phenotypes emerge during social stress modifying hippocampal orexin receptor gene expression

  2024cites this paper
• The Role of Silymarin in Mitigating Inflammation and Cognitive Impairment Induced by Ovariectomy in Wistar Rats

  2023cites this paper
• Maternal exposure to silicon dioxide nanoparticles reduces hippocampal neurogenesis and synaptogenesis and induces neurodegeneration in rat offspring hippocampus

  2022cites this paper
• Differential impacts on multiple forms of spatial and contextual memory in diazepam binding inhibitor knockout mice

  2019cites this paper
• Effects of Selective Serotonin Reuptake Inhibitors on the Shock-Induced Ultrasonic Vocalization of Rats in Different Experimental Designs

  2018cites this paper
• Short-term and long-term effects of diazepam on the memory for discrimination and generalization of scopolamine

  2017cites this paper
• Preclinical evidence implicating corticotropin‐releasing factor signaling in ethanol consumption and neuroadaptation

  2015cites this paper
• The Effects of Norharmane on Memory Retention, Passive Avoidance Learning of Alzheimer's Rats Model by Streptozotocin

  2015cites this paper
• EFFECTS OF CHRONIC ADMINISTRATION OF NORHARMAN ON SPATIAL LEARNING AND MEMORY IN FEMALE RATS

  2014cites this paper
• Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.

  2013cites this paper
• Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization test.

  2012cites this paper
• Effects of positive modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors in a benzodiazepine-induced deficit of spatial discrimination in mice

  2012cites this paper
• Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.

  2012cites this paper
• Dissection of Forebrain Corticotropin-Releasing Hormone Receptor 1 Signaling in Stress-Induced Cognitive Deficits –– The Role of Synaptic Cell Adhesion Molecules

  2011cites this paper
• Dépendance aux drogues opiacées : focus sur le système corticotropin-releasing factor

  2011cites this paper
• Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling.

  2011cites this paper
• mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration.

  2010cites this paper
• The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers.

  2009cites this paper
• Post-training administration of corticotropin-releasing hormone (CRH) enhances retention of a spatial memory through a noradrenergic mechanism in male rats.

  2008cites this paper
• The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists.

  2006cites this paper
• Interactions between CRF and acetylcholine in the modulation of cognitive behaviour.

  2006cites this paper
• Analysis of the Stress Response in Rats Trained in the Water-Maze: Differential Expression of Corticotropin-Releasing Hormone, CRH-R1, Glucocorticoid Receptors and Brain-Derived Neurotrophic Factor in Limbic Regions

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Can CRF1 receptor antagonists become antidepressant and/or anxiolytic agents?

  2005cites this paper
• The Role of Silymarin in Mitigating In fl ammation and Cognitive Impairment Induced by Ovariectomy in Wistar Rats

  year unknowncites this paper